Nisa Investment Advisors, LLC Rubius Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.79 - $5.98 $33,101 - $250,562	-41,900 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$4.25 - $10.4 $174,675 - $427,440	41,100 Added 5137.5%	41,900 $231,000
Q3 2021 Oct 18, 2021	SELL	$17.6 - $25.91 $1.14 Million - $1.68 Million	-65,000 Reduced 98.78%	800 $14,000
Q2 2021 Aug 06, 2021	BUY	$22.26 - $28.43 $1.46 Million - $1.87 Million	65,800 New	65,800 $1.61 Million
Q4 2020 Jan 25, 2021	SELL	$4.23 - $8.73 $2,030 - $4,190	-480 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$3.74 - $9.84 $1,795 - $4,723	480 New	480 $2,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.